MOONLAKE IMMUNOTHERAPEUTICS

Ticker: MLTX CUSIP: 61559X104 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,571,071 Value ($000) $20,707 Avg Close $11.80 Range $6.56 - $15.55
Q3 2025
Shares 1,699,235 Value ($000) $12,184 Avg Close $52.12 Range $5.95 - $62.75
Q2 2025
Shares 423,170 Value ($000) $19,974 Avg Close $40.73 Range $31.42 - $52.88
Q1 2025
Shares 78,835 Value ($000) $3,080 Avg Close $43.09 Range $36.52 - $56.00
Q4 2024
Shares 206,568 Value ($000) $11,186 Avg Close $51.06 Range $45.24 - $58.26
Q3 2024
Shares 360,200 Value ($000) $18,161 Avg Close $46.86 Range $39.36 - $55.74
Q2 2024
Shares 584,263 Value ($000) $25,690 Avg Close $42.36 Range $37.55 - $50.28
Q1 2024
Shares 424,695 Value ($000) $21,332 Avg Close $54.24 Range $42.43 - $64.98
Q4 2023
Shares 598,510 Value ($000) $36,144 Avg Close $51.54 Range $35.11 - $63.77
Q3 2023
Shares 234,250 Value ($000) $13,352 Avg Close $55.20 Range $47.33 - $63.40
Q2 2023
Shares 69,341 Value ($000) $3,536 Avg Close $26.91 Range $17.82 - $55.55
Q1 2023
Shares 197,707 Value ($000) $4,229 Avg Close $16.81 Range $10.50 - $25.32
Q4 2022
Shares 217,999 Value ($000) $2,289 Avg Close $8.89 Range $7.05 - $10.60
Q3 2022
Shares 99,874 Value ($000) $795 Avg Close $7.04 Range $5.13 - $10.27